Since plasma shows lower cfDNA concentrations compared to serum, we tested the methylation frequency of SPAG6, PER1, NKX2-6 and ITIH5 in a plasma cohort, consisting of women with a benign breast disease (n = 14) and invasive breast cancer (n = 111). This evidence concerns the gene PER1 and breast fibrocystic disease.